Cardiovascular disease (CVD), particularly acute coronary syndrome (ACS), is the leading cause of death globally, with risk factors ranging from non-modifiable, like age and family history, to modifiable ones such as dyslipidemia and hypertension.
A study involving 62 STEMI patients and 20 non-ACS CAD patients investigated the correlation between apolipoproteins and ACS, revealing distinct differences in apoA1 levels and the apoB/apoA1 ratio between the two groups.
The findings indicate that hypertension and apoA1 are significant risk factors for STEMI, suggesting that monitoring these can help identify individuals at risk for myocardial infarction.